BCG vaccination reduces haematogenous complications of primary tuberculosis infection.
Is it true that BCG vaccination reduces haematogenous complications of primary tuberculosis infection?
Yes. Evidence shows that the BCG vaccination protects against severe disseminated forms of tuberculosis, including haematogenous complications, particularly in infants.
Verdict: SUPPORTED · 2 sources for, 0 against · Last checked
The retrieved literature consistently supports the well-established immunological finding that BCG vaccination prevents severe disseminated and childhood forms of tuberculosis resulting from primary infection.
Get citation
J, L., A, Z., J, T., G, W., Y, S., L, Z., & C, Q. (2020). Tuberculosis vaccine development: from classic to clinical candidates.. doi.org. https://doi.org/10.1007/s10096-020-03843-6
See more details
Get citation
Kelly, P., McKeown, D., & Clancy, L. (1997). Neonatal BCG vaccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis. doi.org. https://doi.org/10.1183/09031936.97.10030619
What does the evidence say?
The retrieved literature consistently supports the well-established immunological finding that BCG vaccination prevents severe disseminated and childhood forms of tuberculosis resulting from primary infection.
- Does the BCG vaccine lower haematogenous complications in primary TB?
- Is it true that BCG vaccination prevents blood-borne complications of primary tuberculosis?
- Does getting the BCG shot reduce haematogenous spread from primary TB infection?
- Can the BCG vaccine decrease the risk of haematogenous TB complications?
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work